GFPT2 was knocked down by exogenously introducing siGFPT2, to verify that the HBP enzyme GFPT2 was a target of nutlin-3a in KRAS MT/p53 WT NSCLC cells. Here, KRAS is linked to non-small cell lung carcinoma.